These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35193582)
1. RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma. Chen Y; Chen X; Pan L; Huang Y; Cai Y; Li J; Li Y; Wang S Cancer Cell Int; 2022 Feb; 22(1):92. PubMed ID: 35193582 [TBL] [Abstract][Full Text] [Related]
2. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop. Zheng W; Wang X; Yu Y; Ji C; Fang L Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128 [TBL] [Abstract][Full Text] [Related]
3. [Effects of Emodin Derivative on Cell Cycle, Apoptosis and NF-κB Pathway in Burkitt Lymphoma Cells]. Cheng DF; Yang BX; Liu WJ; Qiu CX; Liao JR; Qiu YY; Liu TB; Hu JD; Wang WF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):474-488. PubMed ID: 33812418 [TBL] [Abstract][Full Text] [Related]
4. DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway. Pan L; Li Y; Zhang HY; Zheng Y; Liu XL; Hu Z; Wang Y; Wang J; Cai YH; Liu Q; Chen WL; Guo Y; Huang YM; Qian F; Jin L; Wang J; Wang SY Oncotarget; 2017 Oct; 8(52):89643-89654. PubMed ID: 29163777 [TBL] [Abstract][Full Text] [Related]
5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034 [TBL] [Abstract][Full Text] [Related]
6. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses. Mosallanejad K; Sekine Y; Ishikura-Kinoshita S; Kumagai K; Nagano T; Matsuzawa A; Takeda K; Naguro I; Ichijo H Sci Signal; 2014 Apr; 7(323):ra40. PubMed ID: 24782566 [TBL] [Abstract][Full Text] [Related]
7. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway. Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771 [TBL] [Abstract][Full Text] [Related]
8. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program. De Leo A; Arena G; Stecca C; Raciti M; Mattia E Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773 [TBL] [Abstract][Full Text] [Related]
10. Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma. Li Y; Zhang Y; Fu M; Yao Q; Zhuo H; Lu Q; Niu X; Zhang P; Pei Y; Zhang K Mol Med Rep; 2012 Sep; 6(3):477-82. PubMed ID: 22735892 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway. Mao S; Jin J; Li Z; Yang W Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33325535 [TBL] [Abstract][Full Text] [Related]
12. RNA helicase DHX15 acts as a tumour suppressor in glioma. Ito S; Koso H; Sakamoto K; Watanabe S Br J Cancer; 2017 Oct; 117(9):1349-1359. PubMed ID: 28829764 [TBL] [Abstract][Full Text] [Related]
13. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30. Ishikawa C; Senba M; Mori N Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461 [TBL] [Abstract][Full Text] [Related]
14. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines. Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625 [TBL] [Abstract][Full Text] [Related]
16. The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma. Tong X; Zhang X; Fan J; Tong Y; Li S; Jin J; Yao H Cancer Biol Ther; 2013 Apr; 14(4):370-7. PubMed ID: 23360784 [TBL] [Abstract][Full Text] [Related]
17. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model. Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852 [TBL] [Abstract][Full Text] [Related]
18. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
19. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP. Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]